A prospective study to assess the efficacy of ketoconazole in the treatment of recurrent vaginal candidiasis.
A prospective study of oral ketoconazole therapy was undertaken in 40 women who suffered from recurrent thrush. Symptoms were relieved within three days for half the women, and two-thirds of the women maintained an absence of symptoms for a period of at least a month. Over 80% of the patients assessed the treatment as being effective, with 90% preferring oral to topical therapy.
Kovacs
G T
GT
Family Planning Association of Victoria, Richmond.
Westcott
M
M
Rusden
J
J
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D003258:Consumer Behavior; D005260:Female; D006801:Humans; D007654:Ketoconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D012008:Recurrence; D012307:Risk Factors; D013607:Tablets; D013997:Time Factors
D013607:Tablets; D007654:Ketoconazole